LinkedIn
icn_podcast Podcasts
View All Upcoming Courses
Specialty
Course Type
Search
Login
Specialty
Aesthetics Cardiology Cataract & Refractive Dermatology General Ophthalmology Glaucoma Neuro-Ophthalmology Oculoplastics Optometry Retina Women's Health View All Courses
Course Type
Evaluation Supplement Multimedia Webinar Podcast In-Person Multi-part Collection
Search
Login
Menu

Preparing for the Future: Updates in Retinal Diseases and Novel Therapies

By: Ehsan Rahimy, MD

Begin Course

This course has expired. You can still review the content but course credit is no longer available.

Webinar Credits: 1

This webinar is one in a series of educational initiatives designed to encourage collaborative care between primary eye care providers and retina specialists who practice in the same regions of the country.

Retina Specialist Ehsan Rahimy, MD, summarizes the current therapy options for diabetic eye disease and wet age-related macular degeneration (AMD) and addresses the challenges facing clinicians tasked with managing patients with these retinal diseases. Dr. Rahimy also provides the latest clinical trial data on pipeline therapies being studied among these patient populations.

Expiration Date: Saturday, December 31, 2022
Release Date: November 10, 2021

Learning Objectives

Upon completion of this activity, the participant should be able to:

  • Describe current therapy options for diabetic eye disease and wet age-related macular degeneration (AMD).
  • Articulate the challenges facing clinicians tasked with managing diabetic retinopathy (DR), diabetic macular edema (DME), and wet AMD.
  • Summarize pipeline candidates that are being developed for these patient populations.

Accreditation and Designation Statement

Sponsored by

Evolve is an approved COPE Administrator.

This activity, COPE Activity Number 122864, is accredited by COPE for continuing education for optometrists. 
This course is approved for 1 hour CE. 
Course #: 75407-PS
Activity #: 122864

Participation Method

In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 11 for Windows
Edge (recent versions; Chromium-based) for Windows
Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Safari (recent versions) for Mac OSX, or iOS

Hardware Requirements:
4GB+ RAM
Recommended internet speed 5Mbps+

Faculty and Disclosures

Ehsan Rahimy, MD

Palo Alto Medical Foundation
Palo Alto, CA

DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.

The following faculty/staff members have the following financial relationships with commercial interests:

Ehsan Rahimy, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Allergan, Apellis, Genentech, Google, and Regeneron Pharmaceuticals. Speaker’s List: Allergan and Regeneron Pharmaceuticals. 

The Evolve staff and planners have no financial relationships with commercial interests.

Disclaimer

OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Genentech, a member of the Roche Group.

Begin Course